Cathay Biotech Inc (688065) — Free Cash Flow Generation Index
Cathay Biotech Inc (688065) has a Free Cash Flow Generation Index of 0.69x as of June 2025. Free cash flow of CN¥173.32 Million represents 1% of operating cash flow (CN¥251.82 Million). Explore 688065 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Cathay Biotech Inc Free Cash Flow Generation Index (2017–2025)
Historical FCF Generation Index trend for Cathay Biotech Inc across 8 annual periods. For the full cash flow conversion analysis, see Cathay Biotech Inc (688065) cash conversion ratio.
Annual Free Cash Flow Generation for Cathay Biotech Inc (2017–2025)
Year-by-year Free Cash Flow Generation Index for Cathay Biotech Inc. Check 688065 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.84x | CN¥-339.34 Million | CN¥404.12 Million | CN¥743.46 Million | ▼ -2979.6% |
| 2024 | -0.03x | CN¥-22.38 Million | CN¥820.93 Million | CN¥843.31 Million | ▲ +98.4% |
| 2023 | -1.76x | CN¥-1.00 Billion | CN¥569.45 Million | CN¥1.57 Billion | ▲ +58.4% |
| 2022 | -4.22x | CN¥-3.39 Billion | CN¥803.67 Million | CN¥4.20 Billion | ▼ -185.0% |
| 2021 | -1.48x | CN¥-880.49 Million | CN¥594.18 Million | CN¥1.47 Billion | ▼ -207.5% |
| 2020 | -0.48x | CN¥-248.15 Million | CN¥514.96 Million | CN¥763.11 Million | ▼ -14.4% |
| 2019 | -0.42x | CN¥-151.52 Million | CN¥359.62 Million | CN¥511.14 Million | ▲ +97.6% |
| 2017 | -17.62x | CN¥-941.64 Million | CN¥53.45 Million | CN¥995.09 Million | — |